Literature DB >> 24166616

Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.

Toshiki Yamada1, Naoe Goto, Hisashi Tsurumi, Katsuyoshi Takata, Yasuharu Sato, Tadashi Yoshino, Hisataka Moriwaki, Yusuke Kito, Tamotsu Takeuchi, Hitoshi Iwata.   

Abstract

Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin's lymphoma characterized by chromosomal translocation t(11;14)(q13;q32), positive CD5, and nuclear cyclin D1 overexpression with unfavorable prognosis. We report herein a case of MCL in a 73-year-old male diagnosed with diffuse large B-cell lymphoma (ileal tumor) at another hospital, who subsequently relapsed with CD5-negative MCL. At the 1st relapse, he developed neck lymph node swelling, of which biopsy showed proliferation of atypical large pleomorphic cells with CD5-negativity by both immunohistochemistry and flow cytometry. At the 2nd relapse, he again developed an ileal tumor, of which biopsy showed positivity for CD5, CD20, and cyclin D1. In MCL, CD5-negative expression has sometimes been reported as having pleomorphic and blastoid variants. The present case was also histologically the pleomorphic type, but the CD5 expression changed from negative at the onset and the 1st relapse to positive at the 2nd relapse. This is a rare and interesting case because of the different expression of CD5 at all stage. This phenomenon made the diagnosis of MCL difficult.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166616     DOI: 10.1007/s00795-013-0060-x

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  12 in total

1.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

2.  Mantle cell lymphoma: a clinicopathologic study of 80 cases.

Authors:  L H Argatoff; J M Connors; R J Klasa; D E Horsman; R D Gascoyne
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

Review 3.  From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades.

Authors:  Steven H Swerdlow; Michael E Williams
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

4.  Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma.

Authors:  C Cameron Yin; L Jeffrey Medeiros; Candy C Cromwell; Ashwini P Mehta; Pei Lin; Rajyalakshmi Luthra; Lynne V Abruzzo
Journal:  Mod Pathol       Date:  2006-10-20       Impact factor: 7.842

5.  Mantle cell lymphoma in the ocular adnexal region.

Authors:  Audrey Looi; Randy D Gascoyne; Mukesh Chhanabhai; Joseph M Connors; Jack Rootman; Valerie A White
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

6.  Aberrant Bcl6 protein expression in mantle cell lymphoma.

Authors:  Francisca I Camacho; Juan F García; Juan C Cigudosa; Manuela Mollejo; Patrocinio Algara; Elena Ruíz-Ballesteros; Pablo Gonzalvo; Paloma Martín; Carlos Pérez-Seoane; Joaquín Sánchez-García; Miguel A Piris
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

7.  An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.

Authors:  William G Morice; Janice M Hodnefield; Paul J Kurtin; Curtis A Hanson
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

8.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

Review 9.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

10.  Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period.

Authors:  A J Norton; J Matthews; V Pappa; J Shamash; S Love; A Z Rohatiner; T A Lister
Journal:  Ann Oncol       Date:  1995-03       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.